Boxer Capital Management »

Q32 Bio shares owned by Boxer Capital Management

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by Boxer Capital Management from 13F filings

Historical chart of Boxer Capital Management investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Boxer Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Boxer Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $40M 3.1M 12.74

More positions owned by Boxer Capital Management

Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv SHS (QURE)
Kodiak Sciences (KOD)
Kymera Therapeutics (KYMR)
Definium Therapeutics Com Shs (DFTX)
Replimune Group (REPL)
Celcuity (CELC)
Q32 Bio (QTTB)
Capricor Therapeutics Com New (CAPR)
Precigen (PGEN)
Corcept Therapeutics Incorporated (CORT)
Surrozen Com New (SRZN)
Protagonist Therapeutics (PTGX)

View all positions for Boxer Capital Management

Top funds holding Q32 Bio

OrbiMed Advisors
Boxer Capital Management
Atlas Venture Life Science Advisors
BVF
RA Capital Management
Point72 Asset Management
Opaleye Management
Logos Global Management
Ikarian Capital
Vanguard Capital Management
Acorn Capital Advisors
Woodline Partners
American Century Companies
Sanofi
Acadian Asset Management

View all funds holding Q32 Bio